Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

36.20
Delayed Data
As of 4:00pm ET
 +0.22 / +0.61%
Today’s Change
29.83
Today|||52-Week Range
36.60
+11.45%
Year-to-Date
Sabal Trust CO Buys United Parcel Service Inc, Bristol-Myers Squibb Company, Hanesbra...
6:39pm / GuruFocus News - Paid Partner Content
Stearns Financial Services Group Buys iShares Core U.S. ...
2:39pm / GuruFocus News - Paid Partner Content
Aerie (AERI) Up on FDA Review Committee Result for Rhopressa
6:31pm / Zacks.com - Paid Partner Content
J&J (JNJ) Beats on Q3 Earnings, Actelion Buyout Drives Sales
11:08am / Zacks.com - Paid Partner Content
Dow Jones and S&P 500 Close at New Highs
5:11pm / GuruFocus News - Paid Partner Content
Zacks Industry Outlook Highlights: Gilead, Teva, Pfizer and Amgen
10:19am / Zacks.com - Paid Partner Content
Comprehensive Portfolio Management, LLC Buys PolarityTE Inc, Pfizer Inc, SPDR Nuveen ...
4:38pm / GuruFocus News - Paid Partner Content
Pharma Industry Outlook - October 2017
Oct 16 / Zacks.com - Paid Partner Content
Innovative Pipelines & Regulatory Catalysts to Drive Pharma Stocks
4:03pm / Zacks.com - Paid Partner Content
J&J's Psoriasis Drug Stelara Gets FDA Nod for Adolescent Use
Oct 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close35.98
Today’s open35.93
Day’s range35.75 - 36.33
Volume14,019,661
Average volume (3 months)17,419,833
Market cap$214.3B
Dividend yield3.54%
Data as of 4:00pm ET, 10/17/2017

Growth & Valuation

Earnings growth (last year)+5.09%
Earnings growth (this year)+6.65%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+8.13%
P/E ratio26.4
Price/Sales3.79
Price/Book3.67

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.03-0.03%
MRKMerck-0.12-0.19%
SNYSanofi-0.04-0.08%
ABBVAbbVie+1.13+1.24%
Data as of 4:02pm ET, 10/17/2017

Financials

Next reporting dateOctober 31, 2017
EPS forecast (this quarter)$0.64
Annual revenue (last year)$52.8B
Annual profit (last year)$7.2B
Net profit margin13.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts